FIELD: chemistry.
SUBSTANCE: novel derivatives of 4-phenyltetrahydroisoquinolines have total formula I:  , in which R1, R2, R3 and R4 independently on each other represent H, F, CI, Br, I, alkyl with 1, 2, 3 or 4 C-atoms; R5 represents H, alkyl with 1, 2, 3 or 4 C-atoms; R6 represents H, alkyl with 1, 2, 3 or 4 C-atoms; R7, R8 and R9 independently on each other represent H, COOR60, -L-G; R60 represents H, alkyl with 1, 2, 3, 4, 5, 6, 7 or 8 C-atoms; L represents -NR30CO-, -CONR30-, -NR30CONR31-, -NR30COO-; and R30 and R31 independently on each other represent H; G represents groups Ca(OR32)xH2a+1-x, and one or more CH2-groups can be substituted with O; Cb(OR32)yH2b-1-y,and one or more CH2-groups can be substituted with O; CcH2c+1 and two or more CH2- groups can be substituted with O; -(CH2)z-COOR34, where atom of H group -(CH2)z - can be substituted with group OR32; -CR38R39-COOR40, -(CH2)Z-SO3R34; -(CH2)z-N+R35R36R37; -CR38R39NR41R42; a is equal 2, 3, 4, 5 or 6; x is equal 2, 3, 4, or 5 R32 represents H; b is equal 6; y is equal 4; c is equal 5; z is equal 1 or 2; R34, R35, R36 and R37 independently on each other represent H or alkyl with 1, 2, 3, 4, 5 or 6 C-atoms; R38 represents -(CH2)n-Y; n is equal 1 or 3; Y represents H, -COOR44, -CONR45R46, -NHC(NH)NH2, imidazole -4-yl; R44, R45 and R46 independently on each other represent H; R39 represents H; R40 represents H, alkyl with 1, 2, 3, 4, 5, 6, 7 or 8 C-atoms; R41 and R42 independently on each other represent H; and, at least, one of residues of R7, R8 or R9 must represent group -L-G, as well as their pharmaceutically acceptable salts and salts of trifluoroacetic acid. Invention also relates to medication and its application for treatment and prevention of number of diseases.
, in which R1, R2, R3 and R4 independently on each other represent H, F, CI, Br, I, alkyl with 1, 2, 3 or 4 C-atoms; R5 represents H, alkyl with 1, 2, 3 or 4 C-atoms; R6 represents H, alkyl with 1, 2, 3 or 4 C-atoms; R7, R8 and R9 independently on each other represent H, COOR60, -L-G; R60 represents H, alkyl with 1, 2, 3, 4, 5, 6, 7 or 8 C-atoms; L represents -NR30CO-, -CONR30-, -NR30CONR31-, -NR30COO-; and R30 and R31 independently on each other represent H; G represents groups Ca(OR32)xH2a+1-x, and one or more CH2-groups can be substituted with O; Cb(OR32)yH2b-1-y,and one or more CH2-groups can be substituted with O; CcH2c+1 and two or more CH2- groups can be substituted with O; -(CH2)z-COOR34, where atom of H group -(CH2)z - can be substituted with group OR32; -CR38R39-COOR40, -(CH2)Z-SO3R34; -(CH2)z-N+R35R36R37; -CR38R39NR41R42; a is equal 2, 3, 4, 5 or 6; x is equal 2, 3, 4, or 5 R32 represents H; b is equal 6; y is equal 4; c is equal 5; z is equal 1 or 2; R34, R35, R36 and R37 independently on each other represent H or alkyl with 1, 2, 3, 4, 5 or 6 C-atoms; R38 represents -(CH2)n-Y; n is equal 1 or 3; Y represents H, -COOR44, -CONR45R46, -NHC(NH)NH2, imidazole -4-yl; R44, R45 and R46 independently on each other represent H; R39 represents H; R40 represents H, alkyl with 1, 2, 3, 4, 5, 6, 7 or 8 C-atoms; R41 and R42 independently on each other represent H; and, at least, one of residues of R7, R8 or R9 must represent group -L-G, as well as their pharmaceutically acceptable salts and salts of trifluoroacetic acid. Invention also relates to medication and its application for treatment and prevention of number of diseases.
EFFECT: novel derivatives of 4-phenyltetrahydroisoquinalines, which have inhibiting effect on NHE3.
14 cl, 2 tbl, 47 ex
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINE, THEIR USING AS MEDICINAL AGENT AND MEDICINAL AGENT COMPRISING THEREOF | 2002 | 
										Khofmajster ArminKhajnel'T UveLang Khans-JokhenBljajkh MarkusVirt KlausGekle Mikhel' | RU2298003C2 | 
							
              
                | SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, PREPARATION METHOD, APPLICATION AS MEDICINAL AGENTS, AND ALSO MEDICINAL AGENTS CONTAINING THEM | 2005 | 
										Khajnel'T UveLang Khans-JokhenVirt KlausLikher TomasKhofmajster Armin | RU2398766C2 | 
							
              
                | NOVEL 1,2-DIPHENYLAZEAZETHIDINONES, THEIR USING IN TREATMENT OF LIPID METABOLISM DISORDER, MEDICINAL AGENT AND METHOD FOR ITS PREPARING | 2001 | 
										Glombik KhajnerKramer VernerFlor ShtefaniFrik VendelinKhojer KhubertJene GerkhardLindenshmidt AndreasShefer Khans-Ljudvig | RU2286985C2 | 
							
              
                | PHENYLTETRAHYDROISOQUINOLINE COMPOUND, SUBSTITUTED WITH HETEROARYL | 2015 | 
										Kuroda, ShoichiKawabe, KenichiUshiki, YasunobuOhta, HiroshiUneuchi, FumitoShibata, TsuyoshiTabuse, HideakiMunemoto, EijiChonan, Sumi | RU2703456C2 | 
							
              
                | TETRAHYDROCARBAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC AGENT THEREOF, METHOD OF TREATING AND/OR PREVENTING PHYSIOLOGICAL AND/OR PATHOLOGICAL CONDITIONS MEDIATED BY LHRH RECEPTOR BY ABOVE DERIVATIVES | 2008 | 
										Baasner Sil'KeGjunter EhkkhardPaulini KlausPolimeropulos Ehmmanuehl'Tajfel Mikhaehl'Shmidt PeterShuster Til'Man | RU2497806C9 | 
							
              
                | SUBSTITUTED AMINOALKYLAMINOPYRIDINES AND DRUG ON SAID | 1994 | 
										Bernkhard Kol'Gerkhard GrundlerVol'Fgang Opferkukh | RU2135492C1 | 
							
              
                | NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED THEREON, USE THEREOF AND METHOD OF TREATING AND/OR PREVENTING DISEASE | 2009 | 
										Uto JosikazuKarasava KhirosiTakaisi Kijosumi | RU2474575C2 | 
							
              
                | ESTERS OF SULFURIC ACID AND SUGAR ALCOHOLS OR THEIR SALTS, DRUGS AND METHOD OF SYNTHESIS OF COMPOUNDS | 1995 | 
										Aleksandr KukolovskiJurgen FingerleNiggi IbergGans Peter MehrkiRita MjullerMikhael' PekhMariann RuzhZherar ShmidTomas CheppGans Peter Vessel' | RU2139854C1 | 
							
              
                | NOVEL HETEROCYCLIC DERIVATIVES AND THEIR MEDICINAL USING | 2002 | 
										Matsui KhirosiKobajasi KhideoAzukizava SatoruKasaj MasajasuJosimi AkikhisaSirakhase Khiroaki | RU2287529C2 | 
							
              
                | SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF PATIENT TREATMENT, INTERMEDIATE COMPOUND | 1993 | 
										Dzhen M.BrajtUillard M.Uehlch | RU2130453C1 |